Los Angeles pharmacy owners found guilty in $35M fraud scheme

Two Los Angeles men were convicted in a $35 million Medicare fraud scheme. (studiocasper/iStock)

Two Los Angeles-area pharmacy owners have been found guilty for their role in a $35 million scheme to defraud Medicare. 

Aleksander Suris, 51, and Maxim Sverdlov, 44, both of Sherman Oaks, California, were each convicted by a jury this week on one count of conspiracy to commit healthcare fraud and one count of conspiracy to commit money laundering, the Department of Justice announced

Suris was also found guilty of one additional count of conspiracy to commit healthcare fraud and six counts of healthcare fraud, according to DOJ. In addition, both were found not guilty on three more fraud charges. 

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

RELATED: Patients treated by fraudulent providers often most vulnerable, study finds 

From 2012 to 2015, the two men conspired to bill Medicare and Cigna for prescriptions that were not actually dispensed to patients visit their pharmacy, Royal Care Pharmacy, according to evidence president at trial. 

The two then collected false invoices for the prescriptions from a co-conspirator to make it look like the prescriptions were purchased and billed properly. The invoices also indicated that Suris and Sverdlov laundered the proceeds from the fraud through the co-conspirator, DOJ said. 

The case was brought under the Medicare Strike Force, a fraud enforcement agency formed in 2007. Since its inception, the strike force has charged close to 4,000 defendants in Medicare fraud cases totaling nearly $14 billion.

Under President Donald Trump, health officials have made fraud enforcement a focus and increased enforcement of fraud cases. 

Suggested Articles

A handful of major healthcare groups and vendors are throwing their weight behind ONC's information blocking proposal.

Employers are rethinking their approach to health benefit design to curb costs—and to stay competitive in a tight job market, a new report shows.

Rebates for Part D drugs grew from 2011 to 2015 but not enough to offset price spikes, a study found.